Systemic Lupus Erythematosus (SLE) is a pathology of unknown cause, characterized by tissue and cellular damage, secondary to production of autoantibodies and to deposition of immunocomplexes. Lupus nephritis is one of the most common complications of SLE. Our purpose is to propose a therapeutic protocol for patients suffering from Lupus nephritis. This consists of Plasmapheresis associated with pharmacological therapy so that dosage of immunosuppressors can be reduced and consequently also the side effects of the pharmacological therapy.
La plasmaferesi associata alla terapia farmacologica nel trattamento della nefrite lupica: nuovo protocollo terapeutico / Russo, Gaspare Elios; Bonello, M; Vitaliano, E; Bosco, M; Maresca, M; DE PAOLA, A; Tedaldi, M; Bisciglia, M. F.; Bauco, B.. - In: LA CLINICA TERAPEUTICA. - ISSN 0009-9074. - STAMPA. - 151:(2000), pp. 9-13.
La plasmaferesi associata alla terapia farmacologica nel trattamento della nefrite lupica: nuovo protocollo terapeutico.
RUSSO, Gaspare Elios;
2000
Abstract
Systemic Lupus Erythematosus (SLE) is a pathology of unknown cause, characterized by tissue and cellular damage, secondary to production of autoantibodies and to deposition of immunocomplexes. Lupus nephritis is one of the most common complications of SLE. Our purpose is to propose a therapeutic protocol for patients suffering from Lupus nephritis. This consists of Plasmapheresis associated with pharmacological therapy so that dosage of immunosuppressors can be reduced and consequently also the side effects of the pharmacological therapy.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
